Another Merger Comes Out of the Crappy Corporate Tax Code

Last week it was GE's bid for Alstom that highlighted the ongoing idiocy of the US corporate tax code.  This week it is Pfizer and AstraZeneca.  You make crappy policy you get crappy results.

Hey, we've been as anti-business in this country the past few years as we've been in two generations.  We don't deserve corporate domiciles.  These are global instittions, they can go where governments don't put a stick in their eyes.